Visit COVID-19 resources

[Skip to Content]

Vitrectomy for primary symptomatic vitreous opacities: an evidence-based review – (Eye Journal AOP)

Mar 04
2016

Vitrectomy for primary symptomatic vitreous opacities: an evidence-based review Eye advance online publication, March 4 2016. doi:10.1038/eye.2016.30 Authors: T Ivanova, A Jalil, Y Antoniou, P N Bishop, J L Vallejo-Garcia & N Patton

  • 4 March 2016

Comment on: ‘Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab’ – (Eye Journal AOP)

Mar 04
2016

Comment on: ‘Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab’ Eye advance online publication, March 4 2016. doi:10.1038/eye.2016.31 Authors: D Călugăru & M Călugăru

  • 4 March 2016

Reply to ‘Comment on: Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab’ – (Eye Journal AOP)

Mar 04
2016

Reply to ‘Comment on: Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab’ Eye advance online publication, March 4 2016. doi:10.1038/eye.2016.32 Authors: L C Olmos, M S Sayed & R K Lee

  • 4 March 2016

Intravitreal aflibercept for choroidal neovascularisation in angioid streaks – (Eye Journal AOP)

Mar 04
2016

Intravitreal aflibercept for choroidal neovascularisation in angioid streaks Eye advance online publication, March 4 2016. doi:10.1038/eye.2016.34 Authors: S Vaz-Pereira, L Collaço, G De Salvo & P van Zeller

  • 4 March 2016

Comment on: ‘Effectiveness of a smartphone application for testing near-visual acuity’ – (Eye Journal AOP)

Mar 04
2016

Comment on: ‘Effectiveness of a smartphone application for testing near-visual acuity’ Eye advance online publication, March 4 2016. doi:10.1038/eye.2016.35 Author: M Rodríguez-Vallejo

  • 4 March 2016